UGI UGI CORP /PA/ Insider Trading

CFO O'Brien sells entire 28,709-share position in UGI for $1.1M at $37.65; holds zero post-transaction

Sean O'Brien, Chief Financial Officer of UGI Corp, executed two separate sales totaling 28,709 shares for $1,080,807.72 on 2025-12-05, reducing his holdings from 28,709 shares to 0 shares—a complete exit of his equity stake. The sales occurred at $37.65 per share against a current price of $37.75 and a 52-week high of $39.55. UGI is reporting negative net income of $163,000,000.00 on $1,394,000,000.00 in quarterly revenue, with a low single-digit P/E of 9.81 and market cap of $8,098,428,715.75. A full liquidation by the CFO during a period of reported operating losses and near 52-week highs presents a material departure from equity ownership and warrants disclosure of the circumstances driving the exit decision.

UGI subsidiary president sold 15,000 shares at $38.68; holds 33,492 shares post-sale

Joseph L. Hartz, President of a UGI subsidiary, sold 15,000 shares for $580,135.50, reducing his stake by 30.9% to 33,492 shares. The sale occurred at $38.68, below the current price of $39.55 and near the 52-week high of $39.55, during a period when the stock has rallied 19.1% over 30 days and 14.2% over 90 days. UGI is currently unprofitable with net income of $-163,000,000.00 for the latest quarter, despite modest annual revenue growth of 1.1%, creating a backdrop where insider sales merit attention. The substantial reduction in a subsidiary president's holdings warrants monitoring alongside the company's ongoing operational losses.

UGI President of Subsidiary Sharp buys 4.8K shares at $33.30 amid 10.6% 30-day price recovery

Sharp Michael, President of a UGI subsidiary, purchased 4,806 shares at $33.30, establishing an initial holding in the stock worth $160,039.80. The transaction occurred as UGI traded at a modest discount to its 52-week high of $34.16, while the stock has recovered 10.6% over the prior 30 days and 16.6% over 90 days. UGI's fundamentals show a $2.0B quarterly revenue base and $375.0M net income, though the company faces a headwind with annual revenue growth of -19.2% year-over-year. The valuation appears reasonable at a P/E of 13.28, but the revenue contraction and the magnitude of Sharp's first-time purchase merit observation against the broader operational context.